SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Stroke
An SI Board Since May 2001
Posts SubjectMarks Bans
70 18 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Indication-specific file folder for stroke.

Intent is to limit discussion, so that the thread can be a reference tool. Chat is fun, however, and is an occasional "must do".
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
70ReNeuron receives DSMB clearance to progress to higher dose in ReN001 stem cell nigel bates-9/1/2011
69Merz Pharmaceuticals Announces Phase III Data for NT 201 in Post-stroke Upper LiDewDiligence_on_SI-10/7/2009
68Boehringer stroke drug (Pradaxa) proves a winner in trial By Ben Hirschler – Sunigel bates-8/31/2009
67<b>Single gene defect can cause stroke, other artery diseases</b> Hidos-5/1/2009
66Contact: Jean-François Huppé jean-francois.huppe@dc.ulaval.ca 418-656-idos-1/27/2009
65Migraines' Frequency Influences Heart Attack, Stroke Risk THURSDAY, April 1nigel bates-4/21/2008
64Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functtnsaf-8/19/2007
63>The change in NIHSS, from day 0 to day 90 was found to be significantly highidos-5/13/2007
62Ark wins key patent case on stroke in Europe London, UK 22 February 2007 - Ark nigel bates-2/22/2007
61D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Panigel bates-1/3/2007
60ReNeuron files IND application to commence human clinical studies with ReN001 stnigel bates-12/7/2006
59NXY-059 Does Not Meet Efficacy Endpoints in Phase III Trial for Acute Ischemic Snigel bates-10/26/2006
58US Army to Conduct Phase 2 Trial of Glypromate(R) to Reduce Brain Injury From Canigel bates-9/4/2006
57Slovak doctor says solar flares could raise strokes By Matt Reynolds Mon May 22nigel bates-5/22/2006
56Antiplatelets Recommended For Prevention Of Recurrent Stroke Or Death Main CLJM-4/22/2006
55Hi Nigel, The main aim of the chant trial is safety and tolerability. The drug dr.praveen-3/14/2006
54Renovis Announces That Headline Results From CHANT Safety and Tolerability Trialnigel bates-3/14/2006
53FibroGen Reports FG-4539, HIF-PH Inhibitor, is Neuroprotective and Significantlynigel bates-2/18/2006
52New England Journal of Medicine Publishes NXY-059 Study, the First Internationalnigel bates-2/9/2006
51Polymer Aids In Blood Clotting, Pointing Way To New Treatment (note:not necessJohn McCarthy-1/26/2006
50PAION and Lundbeck Partner on Phase III Compound Desmoteplase for Acute Stroke nigel bates-7/11/2005
49<B>Phase III Trials for CEROVIVE (NXY-059) Will Continue as Planned FollowPeter H. Proctor-10/14/2004
48Novo-7. New Breakthrough for NovoSeven(R); NovoSeven(R) Effective in Treatment keokalani'nui-6/22/2004
47Astrazeneca, stroke, Cerovive <I>Dr Z: "My view is that "doctriPeter H. Proctor-3/31/2004
46Astrazeneca, Stroke, Cerovive, Renovis, and TRPM7. 1) Like much free radical paPeter H. Proctor-3/30/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News